These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 28040797)
1. Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A. Samanta SK; Sehrawat A; Kim SH; Hahm ER; Shuai Y; Roy R; Pore SK; Singh KB; Christner SM; Beumer JH; Davidson NE; Singh SV J Natl Cancer Inst; 2017 Jun; 109(6):. PubMed ID: 28040797 [TBL] [Abstract][Full Text] [Related]
2. Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model. Hahm ER; Lee J; Kim SH; Sehrawat A; Arlotti JA; Shiva SS; Bhargava R; Singh SV J Natl Cancer Inst; 2013 Aug; 105(15):1111-22. PubMed ID: 23821767 [TBL] [Abstract][Full Text] [Related]
3. Peptidyl-prolyl cis/trans isomerase Pin1 regulates withaferin A-mediated cell cycle arrest in human breast cancer cells. Samanta SK; Lee J; Hahm ER; Singh SV Mol Carcinog; 2018 Jul; 57(7):936-946. PubMed ID: 29603395 [TBL] [Abstract][Full Text] [Related]
4. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells. Kim SH; Singh SV Cancer Prev Res (Phila); 2014 Jul; 7(7):738-47. PubMed ID: 24824039 [TBL] [Abstract][Full Text] [Related]
5. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors. Lee J; Hahm ER; Marcus AI; Singh SV Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234 [TBL] [Abstract][Full Text] [Related]
6. RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells. Hahm ER; Kim SH; Singh KB; Singh SV Mol Carcinog; 2021 Jan; 60(1):3-14. PubMed ID: 33150660 [TBL] [Abstract][Full Text] [Related]
7. Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse model. Singh SV; Kim SH; Sehrawat A; Arlotti JA; Hahm ER; Sakao K; Beumer JH; Jankowitz RC; Chandra-Kuntal K; Lee J; Powolny AA; Dhir R J Natl Cancer Inst; 2012 Aug; 104(16):1228-39. PubMed ID: 22859850 [TBL] [Abstract][Full Text] [Related]
8. Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells. Hahm ER; Singh SV Curr Cancer Drug Targets; 2013 Jul; 13(6):640-50. PubMed ID: 23607597 [TBL] [Abstract][Full Text] [Related]
9. Withaferin A Inhibits Fatty Acid Synthesis in Rat Mammary Tumors. Singh KB; Hahm ER; Kim SH; Singh SV Cancer Prev Res (Phila); 2023 Jan; 16(1):5-16. PubMed ID: 36251722 [TBL] [Abstract][Full Text] [Related]
10. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. Hahm ER; Moura MB; Kelley EE; Van Houten B; Shiva S; Singh SV PLoS One; 2011; 6(8):e23354. PubMed ID: 21853114 [TBL] [Abstract][Full Text] [Related]
11. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Stan SD; Hahm ER; Warin R; Singh SV Cancer Res; 2008 Sep; 68(18):7661-9. PubMed ID: 18794155 [TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer. Hahm ER; Kim SH; Singh KB; Singh K; Singh SV Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824 [TBL] [Abstract][Full Text] [Related]
13. Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin. Hahm ER; Lee J; Abella T; Singh SV Mol Carcinog; 2019 Nov; 58(11):2139-2148. PubMed ID: 31441116 [TBL] [Abstract][Full Text] [Related]
14. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells. Lee J; Hahm ER; Singh SV Carcinogenesis; 2010 Nov; 31(11):1991-8. PubMed ID: 20724373 [TBL] [Abstract][Full Text] [Related]
15. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer. Kim SH; Singh KB; Hahm ER; Singh SV Cancer Prev Res (Phila); 2021 Apr; 14(4):421-432. PubMed ID: 33509807 [TBL] [Abstract][Full Text] [Related]
16. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells. Hahm ER; Lee J; Huang Y; Singh SV Mol Carcinog; 2011 Aug; 50(8):614-24. PubMed ID: 21432907 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in MNU and DMBA-induced mammary tumors in female rats. Alvarado A; Lopes AC; Faustino-Rocha AI; Cabrita AMS; Ferreira R; Oliveira PA; Colaço B Pathol Res Pract; 2017 May; 213(5):441-446. PubMed ID: 28285967 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells. Szarc vel Szic K; Op de Beeck K; Ratman D; Wouters A; Beck IM; Declerck K; Heyninck K; Fransen E; Bracke M; De Bosscher K; Lardon F; Van Camp G; Vanden Berghe W PLoS One; 2014; 9(2):e87850. PubMed ID: 24498382 [TBL] [Abstract][Full Text] [Related]
19. Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice. Wong AW; Dunlap SM; Holcomb VB; Nunez NP Alcohol Clin Exp Res; 2012 Apr; 36(4):577-87. PubMed ID: 21981381 [TBL] [Abstract][Full Text] [Related]
20. Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells. Stan SD; Zeng Y; Singh SV Nutr Cancer; 2008; 60 Suppl 1(Suppl 1):51-60. PubMed ID: 19003581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]